Nektar Therapeutics (NASDAQ:NKTR)

46.18
BATS BZX Real-Time Price
As of 12:54pm ET
 +0.76 / +1.67%
Today’s Change
29.22
Today|||52-Week Range
111.36
+40.49%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close45.42
Today’s open45.55
Day’s range45.17 - 46.61
Volume37,074
Average volume (3 months)2,444,560
Market cap$6.5B
Data as of 12:54pm ET, 01/18/2019

Growth & Valuation

Earnings growth (last year)+43.63%
Earnings growth (this year)+726.77%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratio11.2
Price/Sales30.27
Price/Book67.84

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+2.59+2.05%
TECHBio-Techne Corp+2.15+1.33%
EXASExact Sciences Corp+2.22+2.94%
NBIXNeurocrine Bioscienc...+1.74+1.96%
Data as of 12:55pm ET, 01/18/2019

Financials

Next reporting dateFebruary 28, 2019
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts